CA2671117A1 - Method of using magnetic fields to uniformly induce electric fields for therapeutic purposes - Google Patents
Method of using magnetic fields to uniformly induce electric fields for therapeutic purposes Download PDFInfo
- Publication number
- CA2671117A1 CA2671117A1 CA002671117A CA2671117A CA2671117A1 CA 2671117 A1 CA2671117 A1 CA 2671117A1 CA 002671117 A CA002671117 A CA 002671117A CA 2671117 A CA2671117 A CA 2671117A CA 2671117 A1 CA2671117 A1 CA 2671117A1
- Authority
- CA
- Canada
- Prior art keywords
- magnetic field
- orientation
- coil
- approximately
- delivered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 66
- 230000005684 electric field Effects 0.000 title claims abstract description 48
- 230000001225 therapeutic effect Effects 0.000 title description 5
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 201000011510 cancer Diseases 0.000 claims description 5
- 210000005003 heart tissue Anatomy 0.000 claims description 4
- 210000001519 tissue Anatomy 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 14
- 238000011282 treatment Methods 0.000 description 13
- 230000004071 biological effect Effects 0.000 description 11
- 230000005672 electromagnetic field Effects 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 208000010125 myocardial infarction Diseases 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 6
- 229930012538 Paclitaxel Natural products 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 229960001592 paclitaxel Drugs 0.000 description 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 5
- 210000004165 myocardium Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 3
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000022211 Arteriovenous Malformations Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000005744 arteriovenous malformation Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Magnetic Treatment Devices (AREA)
- Variable-Direction Aerials And Aerial Arrays (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/045491 WO2008066509A2 (en) | 2006-11-28 | 2006-11-28 | Method of inducing uniform electric fields |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2671117A1 true CA2671117A1 (en) | 2008-06-05 |
Family
ID=39468388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002671117A Abandoned CA2671117A1 (en) | 2006-11-28 | 2006-11-28 | Method of using magnetic fields to uniformly induce electric fields for therapeutic purposes |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2094356A2 (ja) |
| JP (1) | JP2010510862A (ja) |
| AU (1) | AU2006351238A1 (ja) |
| BR (1) | BRPI0622183A2 (ja) |
| CA (1) | CA2671117A1 (ja) |
| WO (1) | WO2008066509A2 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2672987T3 (es) * | 2009-03-02 | 2018-06-19 | Yeda Research And Development Co. Ltd. | Esquema de configuración magnética y sincronización para la estimulación magnética transcraneal |
| CN108619618A (zh) * | 2018-05-29 | 2018-10-09 | 北京星辰万有科技有限公司 | 一种糖尿病理疗装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004082759A2 (en) * | 2003-03-17 | 2004-09-30 | Trustees Of Boston University | Magnetic stimulator |
-
2006
- 2006-11-28 BR BRPI0622183-1A patent/BRPI0622183A2/pt not_active IP Right Cessation
- 2006-11-28 AU AU2006351238A patent/AU2006351238A1/en not_active Abandoned
- 2006-11-28 CA CA002671117A patent/CA2671117A1/en not_active Abandoned
- 2006-11-28 EP EP06838452A patent/EP2094356A2/en not_active Withdrawn
- 2006-11-28 JP JP2009539219A patent/JP2010510862A/ja active Pending
- 2006-11-28 WO PCT/US2006/045491 patent/WO2008066509A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0622183A2 (pt) | 2011-12-27 |
| AU2006351238A1 (en) | 2008-06-05 |
| WO2008066509A2 (en) | 2008-06-05 |
| EP2094356A2 (en) | 2009-09-02 |
| JP2010510862A (ja) | 2010-04-08 |
| WO2008066509A3 (en) | 2009-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8014846B2 (en) | Methods of using magnetic fields to uniformly induce electric fields for therapeutic purposes | |
| EP1904175B1 (en) | Electromagnetic fields used in cancer and other therapies | |
| Novikov et al. | Effect of weak combined static and extremely low‐frequency alternating magnetic fields on tumor growth in mice inoculated with the Ehrlich ascites carcinoma | |
| US20180110978A1 (en) | Synergistic regulated cell death induction with hsp90 inhibitors and nanosecond pulsed electric fields | |
| US20130261711A1 (en) | Methods to arrest cancer cell growth and proliferation using electromagnetic energy delivered via electromagnetic coil systems | |
| US20050267535A1 (en) | Apparatus and method for interfering with pathological cells survival processes | |
| US9492679B2 (en) | Transcranial magnetic stimulation for altering susceptibility of tissue to pharmaceuticals and radiation | |
| EP3654841B1 (en) | Targeted osmotic lysis of malignant cancer cells using pulsed magnetic field gradients | |
| CA2671117A1 (en) | Method of using magnetic fields to uniformly induce electric fields for therapeutic purposes | |
| Mahna et al. | The effect of ELF magnetic field on tumor growth after electrochemotherapy | |
| JP2007160078A (ja) | 電磁気治療用処置装置及びその使用方法 | |
| Anschel et al. | Evolution of a focal brain lesion produced by interlaced microplanar X-rays | |
| TWI711425B (zh) | 非侵入式熱消融裝置 | |
| KR100479568B1 (ko) | 전자기치료장치 | |
| Barassi et al. | Quantum Medicine and the Immune System | |
| Ali et al. | Solid Ehrlich tumor growth treatment by magnetic waves | |
| JP2011240115A (ja) | ナノ秒パルス電界を用いたアポトーシス誘導方法 | |
| Chen et al. | Time interval after heat stress plays an important role in the combination therapy of hyperthermia and cancer chemotherapy agents | |
| WO2024163837A1 (en) | Electromagnetic radiation treatment | |
| Pappas et al. | Effects of pulsed magnetic field oscillations in cancer therapy | |
| JPH11513907A (ja) | 電磁気治療用処置装置及びその使用方法 | |
| Jäkela et al. | Ion Chamber Dosimetry in a Magnetic Field for MR-Linac Applications | |
| Pappas et al. | RIFE CRANE | |
| Winterberg | Treating Cancer with Strong Magnetic Fields and Ultrasound | |
| Winterberg | On the Disruption of Cell Multiplication by Oscillating Electric Fields |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20121128 |